Supplementary Material for: A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma

Dataset

2017
A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma
Puvvada, S. D., Guillén-Rodríguez, J. M., Rivera, X. I., Heard, K., Inclan, L., Schmelz, M., Schatz, J. H. & Persky, D. O., Dec 1 2017, In: Oncology (Switzerland). 93, 6, p. 401-405 5 p.
Research output: Contribution to journal › Article › peer-review
9 Scopus citations

Research output